Answers are grounded in this paper and cite their sources.
Solid-phase peptide synthesis commonly relies on the application of trifluoroacetic acid (TFA) at the final cleavage and deprotection stage. However, TFA creates safety hazards for personnel and the environment, as well as additional costs due to necessary safety measures, waste disposal, and the conversion of peptide trifluoroacetate salt into the acetate or hydrochloride form. Herein, we describe PFAS-free cleavage and deprotection protocols based on the in situ generation of HCl in formic acid, and their applicability for the removal of side-chain protecting groups and peptide release from Rink amide and Wang resins. The practical utility of the suggested approach is exemplified by the synthesis of a number of cosmetic- and pharmaceutical-grade peptides. While the deprotection process is accompanied by the formylation of Ser, Thr, Tyr, and Trp, the desired product can be easily recovered by treatment with an appropriate nucleophile. It was found that depending on the peptide sequence, the purity and yield of the crude product can be at least comparable to those of the standard TFA procedure for lab-scale synthesis and hectogram-scale peptide production.
No takes yet. Share an insight, caveat, or question.
Leko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: